We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
British travellers to the US must register with the Electronic System for Travel Authorisation (ESTA) before their journey
Deputy Ambassador Deirdre Brown commends the work of the OSCE Mission, particularly during a critical year for Moldova.
This guide sets out who has to apply for a permit, how to apply and explains the other rules covering travel to Antarctica.
Ambassador Holland responds to the report presentation by Ambassador Wahl, Head of the OSCE Mission to Skopje.
Employment Appeal Tribunal Judgment of Judge Tayler on 16 April 2024.
Employment Appeal Tribunal Judgment of Judge Shanks on 16 April 2024.
Employment Appeal Tribunal Judgment of Mrs Justice Eady on 18 April 2024.
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
Statement by Ambassador Barbara Woodward at the UN Security Council meeting on the Middle East.
Using an ecological momentary assessment to evaluate your digital health product.
Information about incidents and outbreaks of Ebola and Marburg, both viral haemorrhagic fevers (VHF).
Latest FCDO travel advice for Mexico including on entry requirements, safety and security and local laws and customs.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.